| Phase 3 | 2 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT02429687 | TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors | Ovarian Germ Cell Cancer | Recruiting | 2023-04-25 |
| NCT02429700 | TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors | Ovarian Sex Cord Stromal Tumor | Recruiting | 2023-04-25 |
| Not specified | ||||
| NCT07153705 | OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study… | Ovarian Cancer | Not Yet Recruiting | 2025-09-04 |
Ovarian Cancer (3)